A Heavy Burden on Developing Nations
Globally, over half a billion people are living with respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease. While these illnesses affect people everywhere, the burden falls disproportionately on low- and middle-income countries, where more than 90 percent of premature deaths occur.
In countries like Nigeria, these diseases are frequently underdiagnosed and undertreated. Many patients struggle to access diagnostic services, essential medicines, and specialised care. As a result, respiratory illnesses often progress silently, eroding health and productivity over many years before becoming fatal.
Public health advocates have repeatedly pointed out that CRDs remain largely “invisible” in global health discussions. Unlike infectious disease outbreaks that trigger immediate emergency responses and international attention, respiratory conditions develop gradually. Their slow progression means the suffering they cause often unfolds out of sight, even though the cumulative impact is enormous.
Inequality and Policy Gaps
The disproportionate burden of CRDs in poorer countries highlights the close link between poverty and health outcomes. Essential treatments for respiratory diseases exist and are recognised as cost-effective by the World Health Organization. Yet access to these medicines remains uneven across many developing nations.
Health experts argue that this gap reflects policy failures rather than inevitability. Weak healthcare systems, poor access to medicines, and limited investment in prevention all contribute to the crisis. In many places, environmental regulations are poorly enforced and workplace protections are inadequate, exposing millions of people to preventable respiratory risks.
Air Pollution: A Major Driver
One of the most significant contributors to chronic respiratory disease is air pollution. Harmful particles and toxic gases released from vehicles, industrial processes, and household fuels enter the lungs with every breath.
In many rapidly growing cities, polluted air has become normalised. However, medical research shows there is no safe level of air pollution exposure. Tiny particulate matter can trigger asthma attacks, worsen COPD, and increase the risk of lung cancer and other serious illnesses.
For many experts, air pollution is less an environmental accident than a policy issue. Energy choices, transportation systems, and regulatory enforcement all influence the quality of the air people breathe. When pollution persists, it often reflects political reluctance to challenge powerful industrial and commercial interests.
Tobacco’s Continuing Impact
Tobacco use remains another major cause of respiratory disease worldwide. In many developing countries, tobacco companies continue to market aggressively, often exploiting weak regulatory frameworks.
Although smoke-free laws exist in several nations, enforcement is frequently inconsistent. This leaves millions of people exposed to second-hand smoke and increases the risk of respiratory illness across entire communities.
Public health advocates note that the tobacco industry has long promoted narratives designed to minimise the perceived harms of smoking, slowing down regulatory action in many countries. Stronger policies, public awareness campaigns, and stricter enforcement are widely seen as critical steps in reducing tobacco-related disease.
L-R: Jose Luis Castro, WHO Director-General’s Special Envoy for Chronic Respiratory Diseases; Barry Kistnasamy, Specialist in Community Medicine, focusing on occupational health in South Africa; Professor Richard van Zyl-Smit, Principal Researcher, University of Cape Town (UCT) Lung Institute; Bob Mash, Distinguished Professor, Stellenbosch University, Family Medicine & Primary Care Physician and Linda-Gail Bekker, CEO/Director, Desmond Tutu Health Foundation, South Africa at the opening session of the media workshop on chronic respiratory diseases (CRDs), organised by Jose Luis Castro, WHO Director-General’s Special Envoy for CRDs, together with the Pace Center for Global Health in Cape Town, South Africa, from March 2–6, 2026.
Workplace Exposure Risks
Occupational hazards are another major contributor to chronic respiratory disease. Workers in industries such as mining, construction, manufacturing, and agriculture are often exposed to dust, fumes, and toxic chemicals that damage lung tissue over time.
In many countries, labour protections exist on paper but are poorly enforced in practice. Without proper protective equipment, monitoring, and workplace safety standards, millions of workers remain vulnerable to long-term respiratory illness.
These exposures illustrate how CRDs are not only medical issues but also the result of broader systemic failures in labour policy and industrial regulation.
Human and Economic Consequences
The impact of chronic respiratory diseases extends far beyond health statistics. These conditions reduce productivity, strain healthcare systems, and deepen economic inequality.
Children living with respiratory illness may struggle to participate fully in school. Adults often face reduced work capacity due to persistent cough, breathlessness, and fatigue. Older adults with advanced disease can become increasingly dependent on caregivers and healthcare services.
Collectively, these effects translate into significant economic losses for families, communities, and national economies.
Signs of Progress
Despite the scale of the problem, progress is possible. Some cities have successfully reduced air pollution through stricter environmental regulations and cleaner transportation policies. Other countries have improved access to essential medicines and strengthened smoke-free legislation.
Health systems in several regions are also beginning to integrate respiratory care into primary healthcare services, making diagnosis and treatment more accessible.
These examples demonstrate that when governments prioritise lung health, measurable improvements can occur.
The Need for Accountability
Experts argue that addressing chronic respiratory diseases requires stronger accountability at multiple levels. Governments must enforce environmental standards, regulate tobacco effectively, and ensure equitable access to essential medicines.
International organisations must also place greater emphasis on CRDs within global health priorities, recognising the enormous human and economic costs associated with them.
The media, public health advocates, and civil society groups all play a role in raising awareness and pushing for policy change. Without sustained pressure, respiratory diseases risk remaining overlooked despite their devastating impact.
A Matter of Justice and Public Policy
Lung health reflects the collective choices societies make about energy, transportation, labour protections, and environmental regulation. The air people breathe and the protections available to workers are shaped by policy decisions, not chance.
Chronic respiratory diseases are therefore not simply medical conditions. They represent broader issues of equity, governance, and public accountability. Millions of lives are lost each year to illnesses that are largely preventable or manageable with proper care.
Breaking the silence around CRDs is a crucial step toward meaningful change. For the world’s children, workers, and older adults, the right to breathe clean air and access effective treatment should not remain a neglected priority.